Diversified Trust Co grew its position in Cardiovascular Systems, Inc. (NASDAQ:CSII – Get Rating) by 32.7% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 19,634 shares of the medical device company's stock after buying an additional 4,834 shares during the period. Diversified Trust Co's holdings in Cardiovascular Systems were worth $272,000 at the end of the most recent quarter.
Other institutional investors have also modified their holdings of the company. Point72 Hong Kong Ltd bought a new stake in shares of Cardiovascular Systems in the 2nd quarter valued at about $34,000. PNC Financial Services Group Inc. boosted its holdings in shares of Cardiovascular Systems by 32.1% in the 1st quarter. PNC Financial Services Group Inc. now owns 3,025 shares of the medical device company's stock valued at $68,000 after buying an additional 735 shares in the last quarter. Mutual of America Capital Management LLC boosted its holdings in shares of Cardiovascular Systems by 17.1% in the 2nd quarter. Mutual of America Capital Management LLC now owns 6,849 shares of the medical device company's stock valued at $98,000 after buying an additional 1,002 shares in the last quarter. Captrust Financial Advisors boosted its holdings in shares of Cardiovascular Systems by 86.3% in the 1st quarter. Captrust Financial Advisors now owns 4,665 shares of the medical device company's stock valued at $105,000 after buying an additional 2,161 shares in the last quarter. Finally, Group One Trading L.P. boosted its holdings in shares of Cardiovascular Systems by 226.5% in the 1st quarter. Group One Trading L.P. now owns 6,200 shares of the medical device company's stock valued at $140,000 after buying an additional 11,100 shares in the last quarter. 86.61% of the stock is currently owned by institutional investors.
Get Cardiovascular Systems alerts:Cardiovascular Systems Stock Performance
Shares of NASDAQ CSII opened at $13.32 on Monday. The company has a current ratio of 6.22, a quick ratio of 5.20 and a debt-to-equity ratio of 0.08. Cardiovascular Systems, Inc. has a 12 month low of $12.26 and a 12 month high of $23.47. The company has a 50 day simple moving average of $14.08 and a two-hundred day simple moving average of $14.40. The stock has a market cap of $557.87 million, a price-to-earnings ratio of -13.32 and a beta of 0.86.
Cardiovascular Systems (NASDAQ:CSII – Get Rating) last announced its quarterly earnings data on Thursday, November 3rd. The medical device company reported ($0.27) EPS for the quarter, missing the consensus estimate of ($0.24) by ($0.03). Cardiovascular Systems had a negative net margin of 16.40% and a negative return on equity of 15.51%. The business had revenue of $59.67 million for the quarter, compared to analyst estimates of $59.33 million. As a group, analysts predict that Cardiovascular Systems, Inc. will post -0.67 earnings per share for the current year.Analysts Set New Price Targets
A number of research firms have recently weighed in on CSII. Barclays began coverage on shares of Cardiovascular Systems in a report on Wednesday, December 21st. They issued an "equal weight" rating and a $15.00 price target on the stock. StockNews.com began coverage on shares of Cardiovascular Systems in a research note on Wednesday, October 12th. They issued a "hold" rating for the company. Finally, Lake Street Capital began coverage on shares of Cardiovascular Systems in a research note on Wednesday, December 14th. They issued a "buy" rating and a $25.00 target price for the company. One analyst has rated the stock with a sell rating, two have issued a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and an average target price of $20.00.
Cardiovascular Systems Company Profile
(Get Rating)
Cardiovascular Systems, Inc, a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products.
Featured Articles
- Get a free copy of the StockNews.com research report on Cardiovascular Systems (CSII)
- MarketBeat: Week in Review 12/19 – 12/23
- These Steelmakers Deserve A Place On Your 2023 Watch List
- Inflation Cools, Where Does The S&P 500 Go Now
- Cintas Beats Inflation With Operating Leverage
- Your Decision to Buy Palantir May Simply Be a Matter of Time
Want to see what other hedge funds are holding CSII? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardiovascular Systems, Inc. (NASDAQ:CSII – Get Rating).
Receive News & Ratings for Cardiovascular Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiovascular Systems and related companies with MarketBeat.com's FREE daily email newsletter.